Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Ventum Cap Mkts reduced their FY2025 earnings per share estimates for Cresco Labs in a research note issued on Wednesday, November 5th. Ventum Cap Mkts analyst A. Semple now expects that the company will post earnings of ($0.13) per share for the year, down from their prior forecast of ($0.12). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Ventum Cap Mkts also issued estimates for Cresco Labs’ FY2026 earnings at ($0.10) EPS.
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last issued its quarterly earnings results on Friday, November 7th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Cresco Labs had a negative return on equity of 14.25% and a negative net margin of 7.79%.The business had revenue of $165.00 million during the quarter, compared to analyst estimates of $163.74 million.
View Our Latest Stock Analysis on Cresco Labs
Cresco Labs Stock Down 1.6%
CRLBF stock opened at $1.21 on Monday. The firm’s fifty day simple moving average is $1.21 and its 200-day simple moving average is $0.90. The company has a market capitalization of $430.68 million, a P/E ratio of -8.07 and a beta of 1.51. The company has a debt-to-equity ratio of 1.28, a current ratio of 2.49 and a quick ratio of 2.22. Cresco Labs has a 12 month low of $0.43 and a 12 month high of $1.62.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Featured Stories
- Five stocks we like better than Cresco Labs
- The 3 Best Retail Stocks to Shop for in August
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- Business Services Stocks Investing
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- What is diluted earnings per share (Diluted EPS)?
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
